Caixin
Oct 30, 2021 08:00 AM

Chongqing Lummy Pharmaceutical Co.,Ltd.’s Net Profit Rose 413.6% in First Three Quarters of 2021

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net profit of 17 million yuan in the first three quarters of 2021, up 413.6% year-on-year.

Meanwhile, the company posted 891.7 million yuan in revenue, down 16.8% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 656.4 million yuan in total liabilities, with a liability-to-asset ratio of 22%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin China Biz Roundup: Rape Allegations at Acting School Spark Uproar
00:00
00:00/00:00